Becker's Healthcare January 31, 2025
Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street Journal reported Jan. 28.
Here are five things to know:
- This modest price increase is a dip from last year’s 4.5% rise, reflecting a cautious approach as drug companies may try to avoid criticism from President Donald Trump while seeking his support for key industry priorities, the report said.
- The price hikes affect well-known drugs produced by companies such as Pfizer, Novartis and Bristol-Myers Squibb, according to an analysis for the Journal by 46brooklyn, a nonprofit research group.
- The...